BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Daxor Corporation (DXR) Announces Placement of BVA-100 Blood Volume Analyzer at New York Presbyterian/Weill Cornell Medical College


7/18/2012 8:37:33 AM

NEW YORK, NY--(Marketwire - July 18, 2012) -

Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, today announced the placement of Daxor's BVA-100 Blood Volume Analyzer at New York Presbyterian/Weill Cornell Medical Center.

Tracing their roots back to 1771, the New York Presbyterian/Weill Cornell Medical Center is one of the most acclaimed healthcare institutions in history. New York Presbyterian is a Level I Trauma Center for pediatric and adult patients, as well as a Stroke, Hyperbaric, PCI and Burn Center. Based in New York City, they are the nation's largest not-for-profit, non-sectarian hospital, with 2,409 beds. The Hospital has nearly 2 million inpatient and outpatient visits in a year, including 12,797 deliveries and 195,294 visits to its emergency departments. NewYork-Presbyterian's 6,144 affiliated physicians and 19,376 staff provide state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine at five major centers: The Allen Hospital, Morgan Stanley Children's Hospital of New York-Presbyterian, New York-Presbyterian Hospital/Columbia University Medical Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York-Presbyterian Hospital/Westchester Division.

New York Presbyterian has just been ranked #7 in the 2012 U.S. News and World Report for Best Hospitals in the entire United States and #1 in the New York/New Jersey region.

James A. Osorio, MD, Assistant Professor of Anesthesiology and Critical Care Fellowship Program Director Critical Care Medicine, said, "We are looking forward to bringing blood volume analysis to our hospital. We see it fit for fluid management of our patients in the Cardiothoracic, Burn and Surgery/Trauma ICU."

Daxor Corporation manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.


Daxor Contact Information:
Richard Dunn
Director of Operations
212-330-8502
rdunn@daxor.com

Diane Meegan
Investor Relations
212-330-8512
dmeegan@daxor.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->